Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment.
Saved in:
| Title: | Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment. |
|---|---|
| Authors: | Kuusalo L; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. laura.kuusalo@utu.fi., Venäläinen MS; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.; Department of Medical Physics, Turku University Hospital, Turku, Finland., Kirjala H; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland., Saranpää S; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland., Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Pirilä L; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. |
| Source: | Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12943. Date of Electronic Publication: 2023 Aug 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
